Literature DB >> 34903557

Unequal global vaccine coverage is at the heart of the current covid-19 crisis.

Fatima Hassan1, Leslie London2, Gregg Gonsalves3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34903557     DOI： 10.1136/bmj.n3074

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue.

Authors:  Zhonglei Wang; Liyan Yang
Journal:  Front Public Health       Date:  2022-06-17

2.  Time-Dependent Changes in Death Reports and the Sex Ratio in the Safety Surveillance of SARS-CoV-2 Vaccination in Japan, the United States, and European Countries.

Authors:  Erika Yamashita; Morihito Takita; Masahiro Kami
Journal:  Cureus       Date:  2022-03-22

3.  Vaccine apartheid: global cooperation and equity.

Authors:  Simar Singh Bajaj; Lwando Maki; Fatima Cody Stanford
Journal:  Lancet       Date:  2022-02-23       Impact factor: 202.731

4.  Social justice now for an equitable tomorrow: Reflections from the Consortium of Universities for Global Health Conference 2022.

Authors:  Beryne Odeny; Callam Davidson
Journal:  PLoS Med       Date:  2022-04-22       Impact factor: 11.069

5.  The level and determinants of COVID-19 vaccine acceptance in Ghana.

Authors:  Grace Adjei Okai; Gordon Abekah-Nkrumah
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

6.  Bibliometric Analysis of Publications on the Omicron Variant from 2020 to 2022 in the Scopus Database Using R and VOSviewer.

Authors:  Hasan Ejaz; Hafiz Muhammad Zeeshan; Fahad Ahmad; Syed Nasir Abbas Bukhari; Naeem Anwar; Awadh Alanazi; Ashina Sadiq; Kashaf Junaid; Muhammad Atif; Khalid Omer Abdalla Abosalif; Abid Iqbal; Manhal Ahmed Hamza; Sonia Younas
Journal:  Int J Environ Res Public Health       Date:  2022-09-29       Impact factor: 4.614

7.  Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

Authors:  Molebogeng X Rangaka; Yohhei Hamada; Ibrahim Abubakar
Journal:  Lancet Respir Med       Date:  2022-03-23       Impact factor: 102.642
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.